33 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Guidelines # ... Therapy #regimens #medications ... #pharmacology # ... IDSA #Guidelines ... #Treatment
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... #Antibiotics #Treatment ... Regimen #Management #Guidelines ... #pharmacology
Asymptomatic Bacteriuria - IDSA Indications for Treatment
Healthy non-pregnant women - NO
Healthy pregnant women - YES
Functionally impaired
Bacteriuria - IDSA ... Treatment Healthy ... www.idsociety.org/practice-guideline ... #Bacteriuria #IDSA ... #Indications #Treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... can result in thrombosis ... management #algorithm #pharmacology ... #treatment #medications
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... getting patients on medication ... both of these medications ... HeartFailure #HFrEF #Pharmacology ... #Management #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... the use of this medication ... #Pharmacology #
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for effective treatment ... candida #mucosal #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology